For: | Yang BS, Ma YJ, Wang Y, Chen LY, Bi MR, Yan BZ, Bai L, Zhou H, Wang FX. Protective effect and mechanism of stronger neo-minophagen C against fulminant hepatic failure. World J Gastroenterol 2007; 13(3): 462-466 [PMID: 17230620 DOI: 10.3748/wjg.v13.i3.462] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v13/i3/462.htm |
Number | Citing Articles |
1 |
Jie Yang, Qing-He Nie, An-Hui Wang, Xiao-Feng Huang, Qing-Quan Liu, Yun-Ming Li. Effects of intestinal intervention on bacterial translocation in a rat model of acute liver failure in vivo. European Journal of Gastroenterology & Hepatology 2010; 22(11): 1316 doi: 10.1097/MEG.0b013e32833ccaae
|
2 |
Qing Zhang, Hong Chen, Qin Li, Yunjin Zang, Xinguo Chen, Weilong Zou, Letian Wang, Zhong-yang Shen. Combination adjuvant chemotherapy with oxaliplatin, 5-fluorouracil and leucovorin after liver transplantation for hepatocellular carcinoma: a preliminary open-label study. Investigational New Drugs 2011; 29(6): 1360 doi: 10.1007/s10637-011-9726-1
|
3 |
Irmak Ferah, Zekai Halici, Yasin Bayir, Elif Demirci, Bunyami Unal, Elif Cadirci. The role of infliximab on paracetamol-induced hepatotoxicity in rats. Immunopharmacology and Immunotoxicology 2013; 35(3): 373 doi: 10.3109/08923973.2013.775589
|
4 |
Lingaiah Hari Babu, Srinivasan Perumal, Maruthaiveeran Periyasamy Balasubramanian. Myrtenal, a natural monoterpene, down-regulates TNF-α expression and suppresses carcinogen-induced hepatocellular carcinoma in rats. Molecular and Cellular Biochemistry 2012; 369(1-2): 183 doi: 10.1007/s11010-012-1381-0
|
5 |
Xiaoyue Bi, Liu Yang, Yanjie Lin, Wen Deng, Tingting Jiang, Lu Zhang, Yao Lu, Wei Yi, Yao Xie, Minghui Li. Efficacy and Safety of Glycyrrhizic Acid in Treatment of Autoimmune Hepatitis. The American Journal of Chinese Medicine 2023; 51(02): 391 doi: 10.1142/S0192415X23500209
|
6 |
Brigitte Vollmar, Michael D. Menger. The Hepatic Microcirculation: Mechanistic Contributions and Therapeutic Targets in Liver Injury and Repair. Physiological Reviews 2009; 89(4): 1269 doi: 10.1152/physrev.00027.2008
|
7 |
Chao-Hung Hung, Kwong-Ming Kee, Chih-Hung Chen, Po-lin Tseng, Ming-Chao Tsai, Chien-Hung Chen, Jing-Houng Wang, Kuo-Chin Chang, Yuan-Hung Kuo, Yi-Hao Yen, Tsung-Hui Hu, Sheng-Nan Lu. A Randomized Controlled Trial of Glycyrrhizin Plus Tenofovir vs. Tenofovir in Chronic Hepatitis B with Severe Acute Exacerbation. Clinical and Translational Gastroenterology 2017; 8(6): e104 doi: 10.1038/ctg.2017.29
|
8 |
Su‐Hung Wang, Ming‐Jen Sheu, Hsing‐Tao Kuo, Ching‐Yih Lin, Chi‐Shu Sun, I‐Che Feng. Intravenous glycyrrhizin as a rescue therapy in a patient with latent hepatitis B virus reactivation and acute severe decompensation induced by chemotherapy with rituximab. Advances in Digestive Medicine 2019; 6(2): 77 doi: 10.1002/aid2.13117
|
9 |
Nilanjan Ghosh, Rituparna Ghosh, Vivekananda Mandal, Subhash C. Mandal. Recent advances in herbal medicine for treatment of liver diseases. Pharmaceutical Biology 2011; 49(9): 970 doi: 10.3109/13880209.2011.558515
|
10 |
Neriman Colakoglu, Tuncay Kuloglu, Enver Ozan, Nevin Kocaman, Durrin Ozlem Dabak, Gozde Parlak. Protective effects of vitamin D3 against d-galactosamine-induced liver injury in rats. Tissue and Cell 2016; 48(4): 356 doi: 10.1016/j.tice.2016.05.003
|
11 |
Shin Yasui, Keiichi Fujiwara, Akinobu Tawada, Yoshihiro Fukuda, Masayuki Nakano, Osamu Yokosuka. Efficacy of Intravenous Glycyrrhizin in the Early Stage of Acute Onset Autoimmune Hepatitis. Digestive Diseases and Sciences 2011; 56(12): 3638 doi: 10.1007/s10620-011-1789-5
|
12 |
Hai-Dan Yuan, Guang-Zhu Jin, Guang-Chun Piao. Hepatoprotective effects of an active part from Artemisia sacrorum Ledeb. against acetaminophen-induced toxicity in mice. Journal of Ethnopharmacology 2010; 127(2): 528 doi: 10.1016/j.jep.2009.10.002
|
13 |
Jie Lu, Yong-Ping Chen, Rong Wan, Chuan-Yong Guo, Xing-Peng Wang. Protective Effects of Ulinastatin on Acute Liver Failure Induced by Lipopolysaccharide/d-Galactosamine. Digestive Diseases and Sciences 2012; 57(2): 399 doi: 10.1007/s10620-011-1927-0
|
14 |
Yichuan Xiao, Jingwei Xu, Chaoming Mao, Min Jin, Qiong Wu, Jie Zou, Qiaoli Gu, Yi Zhang, Yanyun Zhang. 18β-Glycyrrhetinic Acid Ameliorates Acute Propionibacterium acnes-induced Liver Injury through Inhibition of Macrophage Inflammatory Protein-1α. Journal of Biological Chemistry 2010; 285(2): 1128 doi: 10.1074/jbc.M109.037705
|
15 |
Hai-Dan Yuan, Guang-Zhu Jin, Guang-Chun Piao. Protective Effects of the Active Part of Artemisia sacrorum Ledeb. against Acetaminophen-Induced Liver Injury in Mice. Biological and Pharmaceutical Bulletin 2009; 32(10): 1683 doi: 10.1248/bpb.32.1683
|
16 |
Hong Zhu, Yang Zhang, Xiaoyu Hu, Cheng Yi, Sen Zhong, Yanyan Wang, Fang Yang. The Effects of High-Dose Qinggan Huoxue Recipe on Acute Liver Failure Induced by D-Galactosamine in Rats. Evidence-Based Complementary and Alternative Medicine 2013; 2013: 1 doi: 10.1155/2013/905715
|
17 |
Gokuladhas Krishnan, Jayakumar Subramaniyan, Pramila Chengalvarayan Subramani, Barath Muralidharan, Devaki Thiruvengadam. Hesperetin conjugated PEGylated gold nanoparticles exploring the potential role in anti-inflammation and anti-proliferation during diethylnitrosamine-induced hepatocarcinogenesis in rats. Asian Journal of Pharmaceutical Sciences 2017; 12(5): 442 doi: 10.1016/j.ajps.2017.04.001
|
18 |
Chunchun Yuan, Jinghui Fan, Lai Jiang, Wenxin Ye, Zhuo Chen, Wenzi Wu, Qixin Huang, Lichun Qian. Integrated Analysis of Gut Microbiome and Liver Metabolome to Evaluate the Effects of Fecal Microbiota Transplantation on Lipopolysaccharide/D-galactosamine-Induced Acute Liver Injury in Mice. Nutrients 2023; 15(5): 1149 doi: 10.3390/nu15051149
|
19 |
Bushra Sultana, Sadaf Yaqoob, Zohaib Zafar, Haq Nawaz Bhatti. Escalation of liver malfunctioning: A step toward Herbal Awareness. Journal of Ethnopharmacology 2018; 216: 104 doi: 10.1016/j.jep.2018.01.002
|
20 |
Jieying Cai, Shiwen Luo, Xueli Lv, Yingguang Deng, Hongyuan Huang, Boxin Zhao, Qing Zhang, Guofeng Li. Formulation of injectable glycyrrhizic acid-hydroxycamptothecin micelles as new generation of DNA topoisomerase I inhibitor for enhanced antitumor activity. International Journal of Pharmaceutics 2019; 571: 118693 doi: 10.1016/j.ijpharm.2019.118693
|